LeMaitre Vascular, Inc. LMAT
Analyst Ratings
- Consensus
- Buy — 3 Buy · 1 Hold · 0 Sell (4 analysts)
- Avg. Price Target
- $114.50 (+41.5% upside)
Key Stats
- Today's Range
- $80.03 – $85.53
- 50-Day Range
- $78.22 – $85.81
- 52-Week Range
- $78.22 – $118.01
- Volume
- 427K shs
- Average Volume
- 266K shs
- Market Cap
- $1.85 billion
- P/E Ratio
- —
- Dividend Yield
- 1.24%
Dividend
- Dividend Yield
- 1.24%
- Annual Dividend
- $1.00
- Payout Ratio
- —
- Ex-Dividend Date
- 2026-08-20
Short Interest
- Short Interest
- 4.36%
- Days to Cover
- 9.98
About LeMaitre Vascular, Inc.
LeMaitre Vascular Inc is a provider of medical devices and human tissue cryopreservation services mainly used in the treatment of peripheral vascular disease, end-stage renal disease, and cardiovascular disease. The company develops, manufactures, and markets vascular devices to address the needs of vascular surgeons and, to a lesser extent, other specialties such as cardiac surgeons, general surgeons, and neurosurgeons. Its diversified portfolio consists of branded products used in arteries and veins that are well known to vascular surgeons. It operates across the Americas, Europe, the Middle East and Africa, and Asia Pacific, with the majority of its revenue generated from the Americas.
Related Stocks
Compare head-to-head: LMAT vs SYK·LMAT vs BSX·LMAT vs RMD·LMAT vs GKOS
Price and fundamental data are delayed and provided for informational purposes only. Not investment advice. See our disclaimer.